BIO-key International
BKYI
6 hedge funds and large institutions have $199K invested in BIO-key International in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 3 → 6 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
6% less capital invested
Capital invested by funds: $211K → $199K (-$12K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$119K |
| 2 |
Jane Street
New York
|
+$14.2K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.32K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.55K |
Top Sellers
BKYI Hedge Fund Activity: Q4 2018 in Review
6 of the 4,504 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q4 2018, worth a combined $199K — down 5.7% from $211K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BKYI positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $119K.
- 6 institutional investors held BIO-key International (BKYI) as of Q4 2018, up from 3 in Q3 2018.
- Funds reported $199K of BIO-key International stock for Q4 2018, down 5.7% quarter-over-quarter.
- 3 funds opened new BIO-key International positions in Q4 2018 and 0 closed out, a net change of +3 holders.
- The largest BIO-key International buyer in Q4 2018 was Vanguard Group, an estimated $119K added.
Based on aggregated 13F filings for Q4 2018.